The presence of mitotic nuclei and the different tumour volumes observed led us to assess the proliferation in E, M and RE-tumours by Ki67 immunostaining, but no significant differences were observed (Figure 4e,f and Figure S7b–h). Here, MKI67 is linked to neoplasm.